Arcutis Biotherapeutics Inc. Revenue 2020–2025
Arcutis Biotherapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arcutis Biotherapeutics Inc. revenue for the quarter ending March 31, 2026 was 105.4 M, a 60.07% increase year-over-year.
- Arcutis Biotherapeutics Inc. revenue for the twelve months ending March 31, 2026 was 352.0 M, a 115.55% increase year-over-year.
- Arcutis Biotherapeutics Inc. annual revenue for 2025 was 376.1 M, a 91.34% increase from 2024.
- Arcutis Biotherapeutics Inc. annual revenue for 2024 was 196.5 M, a 229.74% increase from 2023.
- Arcutis Biotherapeutics Inc. annual revenue for 2023 was 59.6 M, a 1517.09% increase from 2022.
- Arcutis Biotherapeutics Inc. annual revenue for 2022 was 3.7 M.
Arcutis Biotherapeutics Inc. (ARQT) — Frequently Asked Questions
Arcutis Biotherapeutics Inc. (ARQT) is a publicly traded US company. It has a market capitalization of $2.96B. In fiscal 2025 it reported revenue of $376M and net income of -$16M. Explore ARQT's stock price, financial statements, earnings history, margins and key ratios below.
What is Arcutis Biotherapeutics Inc.'s market cap?
Arcutis Biotherapeutics Inc. (ARQT) has a market capitalization of $2.96B.
What is the ARQT stock price?
ARQT trades at $23.23 (+1.93% on the day).
How much revenue does Arcutis Biotherapeutics Inc. make?
Arcutis Biotherapeutics Inc. reported revenue of $376M in fiscal 2025.
Is ARQT profitable?
In fiscal 2025, Arcutis Biotherapeutics Inc. reported net income of -$16M.